Maternal Urine Screening for Down Syndrome: Past Studies and Future Perspectives

Ray Iles; Howard Cuckle

doi:10.1007/s40556-016-0107-x

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00057371.xml

Share / Bookmark

Facebook Linkedin Weibo

Download PDF

CC BY-NC-ND 4.0 · Journal of Fetal Medicine 2016; 03(04): 149-150
DOI: 10.1007/s40556-016-0107-x

Commentary

Maternal Urine Screening for Down Syndrome: Past Studies and Future Perspectives

Ray Iles

¹MAP Diagnostics Ltd, Welwyn Garden City, UK

,

Howard Cuckle

²Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USA

³Faculty of Medicine, Tel Aviv, Israel

› Author Affiliations

› Further Information

Also available at

PDF Download Permissions and Reprints

Keywords

Down Syndrome - Maternal Serum - Hydrophilic Interaction Liquid Chromatography - Syndrome Screening - Maternal Urine

Publication History

Received: 10 August 2016

Accepted: 27 October 2016

Article published online:
08 May 2023

© 2016. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India